Open Payments

The Nebraska Medical Center

Type
Teaching hospital
Where
Omaha, NE
Medicare CCN
280013
Received
$1,334,700 in 137 records, 2024 ($424,642 general, $910,057 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2024General payment93$424,642
2024Research payment44$910,057

By company

CompanyRecordsAmountYears
Genmab U.S., Inc.12$464,3012024
INSTRUMENTATION LABORATORY COMPANY4$160,3872024
Takeda Pharmaceuticals U.S.A., Inc.27$141,1492024
XVIVO Perfusion Inc.1$130,3042024
Genentech USA, Inc.1$100,0002024
OCCLUTECH US LLC1$76,2622024
National Marrow Donor Program4$72,4302024
Zimmer Biomet Holdings, Inc.4$31,2802024
AngioDynamics, Inc.1$30,0002024
Medical Device Business Services, Inc.9$25,0002024
AtriCure, Inc.2$24,1482024
Insulet Corporation20$23,3252024
Olympus America Inc.2$15,6772024
Tandem Diabetes Care, Inc.26$14,7002024
Alnylam Pharmaceuticals Inc.7$10,2502024
Incyte Corporation3$4,9092024
Stryker Corporation3$3,1082024
Teleflex LLC1$2,7882024
Impulse Dynamics (USA) Inc.1$2,5002024
Becton, Dickinson and Company3$5642024
W. L. Gore & Associates, Inc.1$5042024
Mallinckrodt Hospital Products Inc.1$3912024
Monteris Medical Corporation1$2642024
ConvaTec Inc.1$2512024
Siemens Medical Solutions USA, Inc.1$2032024

By nature of payment

NatureRecordsAmount
Research payment44$910,057
Space rental or facility fees (teaching hospital only)22$174,689
Compensation for services other than consulting, including serving as faculty or as a speaker at a v57$120,705
Grant2$76,514
Long term medical supply or device loan4$33,333
Debt forgiveness7$19,381
Education1$20

Records

DateCompanyAmountNatureFormProductStudyYear
2024-12-31OCCLUTECH US LLC$76,262Grant (6 payments)Cash or cash equivalent2024
2024-12-31AngioDynamics, Inc.$30,000Long term medical supply or device loanIn-kind items and servicesAuryon Laser System 100-120 Vac Device, ET2024
2024-12-31Teleflex LLC$2,788Long term medical supply or device loanIn-kind items and servicesWECK Device, SURGICAL2024
2024-12-31Stryker Corporation$1,569Debt forgivenessCash or cash equivalent2024
2024-12-31Stryker Corporation$1,503Debt forgivenessCash or cash equivalent2024
2024-12-31Becton, Dickinson and Company$510Long term medical supply or device loanIn-kind items and services2024
2024-12-31Siemens Medical Solutions USA, Inc.$203Debt forgivenessIn-kind items and services2024
2024-12-31Stryker Corporation$35Debt forgivenessCash or cash equivalent2024
2024-12-31Becton, Dickinson and Company$34Long term medical supply or device loanIn-kind items and services2024
2024-12-27INSTRUMENTATION LABORATORY COMPANY$48,199Research paymentCash or cash equivalentHIT START UP 20222024
2024-12-27INSTRUMENTATION LABORATORY COMPANY$23,370Research paymentCash or cash equivalentL0000024418 FRESH VS FROZEN2024
2024-12-27Zimmer Biomet Holdings, Inc.$5,484Space rental or facility fees (teaching hospital only)Cash or cash equivalentRIBFIX BLU ADVANTAGE Device, CMF & Thoracic2024
2024-12-20Insulet Corporation$550Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentOmnipod Device, Insulin Pump2024
2024-12-18Medical Device Business Services, Inc.$3,600Space rental or facility fees (teaching hospital only)Cash or cash equivalentCARTO 3 Device, Cardiology2024
2024-12-18Tandem Diabetes Care, Inc.$1,000Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2024
2024-12-12Insulet Corporation$550Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentOmnipod Device, Insulin Pump2024
2024-12-11Tandem Diabetes Care, Inc.$800Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2024
2024-12-10INSTRUMENTATION LABORATORY COMPANY$77,901Research paymentCash or cash equivalentL0000024418 FRESH VS FROZEN2024
2024-12-06Medical Device Business Services, Inc.$3,400Space rental or facility fees (teaching hospital only)Cash or cash equivalentCARTO 3 Device, Cardiology2024
2024-12-06Takeda Pharmaceuticals U.S.A., Inc.$2,500Space rental or facility fees (teaching hospital only)Cash or cash equivalent2024
2024-12-05Alnylam Pharmaceuticals Inc.$400Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2024
2024-12-04Tandem Diabetes Care, Inc.$175Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2024
2024-12-02Medical Device Business Services, Inc.$3,200Space rental or facility fees (teaching hospital only)Cash or cash equivalentCARTO 3 Device, Cardiology2024
2024-12-02Medical Device Business Services, Inc.$2,400Space rental or facility fees (teaching hospital only)Cash or cash equivalentCARTO 3 Device, Cardiology2024
2024-11-26Medical Device Business Services, Inc.$3,200Space rental or facility fees (teaching hospital only)Cash or cash equivalentCARTO 3 Device, Cardiology2024
2024-11-26Medical Device Business Services, Inc.$2,400Space rental or facility fees (teaching hospital only)Cash or cash equivalentCARTO 3 Device, Cardiology2024
2024-11-26Medical Device Business Services, Inc.$2,400Space rental or facility fees (teaching hospital only)Cash or cash equivalentCARTO 3 Device, Cardiology2024
2024-11-26Medical Device Business Services, Inc.$1,200Space rental or facility fees (teaching hospital only)Cash or cash equivalentCARTO 3 Device, Cardiology2024
2024-11-25Medical Device Business Services, Inc.$3,200Space rental or facility fees (teaching hospital only)Cash or cash equivalentCARTO 3 Device, Cardiology2024
2024-11-20Takeda Pharmaceuticals U.S.A., Inc.$2,000Space rental or facility fees (teaching hospital only)Cash or cash equivalent2024
2024-11-20Tandem Diabetes Care, Inc.$1,275Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2024
2024-11-20Insulet Corporation$550Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentOmnipod Device, Insulin Pump2024
2024-11-20Mallinckrodt Hospital Products Inc.$391Debt forgivenessCash or cash equivalentINOMAX Drug, CRITICAL CARE2024
2024-11-07Alnylam Pharmaceuticals Inc.$600Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2024
2024-11-06Insulet Corporation$550Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentOmnipod Device, Insulin Pump2024
2024-11-05Takeda Pharmaceuticals U.S.A., Inc.$12,984Research paymentIn-kind items and servicesNINLARO Drug, ONCOLOGYX16104: A PHASE II STUDY OF IXAZOMIB, LENALIDOMIDE, DEXAMETHASONE, AND DARATUMUMAB IN TRANSPLANT-INELIGIBLE PATIENTS WIT2024
2024-11-05Takeda Pharmaceuticals U.S.A., Inc.$4,328Research paymentIn-kind items and servicesNINLARO Drug, ONCOLOGYX16104: A PHASE II STUDY OF IXAZOMIB, LENALIDOMIDE, DEXAMETHASONE, AND DARATUMUMAB IN TRANSPLANT-INELIGIBLE PATIENTS WIT2024
2024-11-04Incyte Corporation$2,059Space rental or facility fees (teaching hospital only)Cash or cash equivalentJAKAFI Drug, Hematology/Oncology2024
2024-10-30Insulet Corporation$750Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentOmnipod Device, Insulin Pump2024
2024-10-25National Marrow Donor Program$18,255Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2024
2024-10-23Takeda Pharmaceuticals U.S.A., Inc.$5,000Space rental or facility fees (teaching hospital only)Cash or cash equivalent2024
2024-10-16Insulet Corporation$550Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentOmnipod Device, Insulin Pump2024
2024-10-10Alnylam Pharmaceuticals Inc.$900Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2024
2024-10-10Insulet Corporation$550Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentOmnipod Device, Insulin Pump2024
2024-10-03Takeda Pharmaceuticals U.S.A., Inc.$4,328Research paymentIn-kind items and servicesNINLARO Drug, ONCOLOGYX16104: A PHASE II STUDY OF IXAZOMIB, LENALIDOMIDE, DEXAMETHASONE, AND DARATUMUMAB IN TRANSPLANT-INELIGIBLE PATIENTS WIT2024
2024-10-02AtriCure, Inc.$10,862Research paymentCash or cash equivalentATRICLIP LAA EXCLUSION SYSTEM Device, CARDIOVASCULARLEFT ATRIAL APPENDAGE EXCLUSION FOR PROPHYLACTIC STROKE REDUCTION TRIAL2024
2024-10-02Insulet Corporation$550Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentOmnipod Device, Insulin Pump2024
2024-09-27Becton, Dickinson and Company$20EducationIn-kind items and services2024
2024-09-23Impulse Dynamics (USA) Inc.$2,500Space rental or facility fees (teaching hospital only)Cash or cash equivalentOptimizer Device, Cardiovascular Device2024
2024-09-20Insulet Corporation$550Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentOmnipod Device, Insulin Pump2024
2024-09-18Tandem Diabetes Care, Inc.$800Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2024
2024-09-13Zimmer Biomet Holdings, Inc.$1,332Space rental or facility fees (teaching hospital only)Cash or cash equivalentRIBFIX BLU ADVANTAGE Device, CMF & Thoracic2024
2024-09-12Genmab U.S., Inc.$5,880Research paymentCash or cash equivalentEpkinly Drug, OncologyA Phase 1/2, Open-Label Safety Trial of GEN3013 in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma.2024
2024-09-11Insulet Corporation$2,025Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentOmnipod Device, Insulin Pump2024
2024-09-09Takeda Pharmaceuticals U.S.A., Inc.$15,534Research paymentCash or cash equivalentELAPRASE Biological, GENETIC DISEASEAN OPEN LABEL EXTENSION OF STUDY HGT-HIT-094 EVALUATING LONG TERM SAFETY AND CLINICAL OUTCOMES OF INTRATHECAL IDURSULFAS2024
2024-09-09Takeda Pharmaceuticals U.S.A., Inc.$7,575Research paymentCash or cash equivalentELAPRASE Biological, GENETIC DISEASEAN OPEN LABEL EXTENSION OF STUDY HGT-HIT-094 EVALUATING LONG TERM SAFETY AND CLINICAL OUTCOMES OF INTRATHECAL IDURSULFAS2024
2024-09-09Takeda Pharmaceuticals U.S.A., Inc.$7,575Research paymentCash or cash equivalentELAPRASE Biological, GENETIC DISEASEAN OPEN LABEL EXTENSION OF STUDY HGT-HIT-094 EVALUATING LONG TERM SAFETY AND CLINICAL OUTCOMES OF INTRATHECAL IDURSULFAS2024
2024-09-09Takeda Pharmaceuticals U.S.A., Inc.$7,575Research paymentCash or cash equivalentELAPRASE Biological, GENETIC DISEASEAN OPEN LABEL EXTENSION OF STUDY HGT-HIT-094 EVALUATING LONG TERM SAFETY AND CLINICAL OUTCOMES OF INTRATHECAL IDURSULFAS2024
2024-09-09Takeda Pharmaceuticals U.S.A., Inc.$7,575Research paymentCash or cash equivalentELAPRASE Biological, GENETIC DISEASEAN OPEN LABEL EXTENSION OF STUDY HGT-HIT-094 EVALUATING LONG TERM SAFETY AND CLINICAL OUTCOMES OF INTRATHECAL IDURSULFAS2024
2024-09-09Takeda Pharmaceuticals U.S.A., Inc.$7,575Research paymentCash or cash equivalentELAPRASE Biological, GENETIC DISEASEAN OPEN LABEL EXTENSION OF STUDY HGT-HIT-094 EVALUATING LONG TERM SAFETY AND CLINICAL OUTCOMES OF INTRATHECAL IDURSULFAS2024
2024-09-09Takeda Pharmaceuticals U.S.A., Inc.$7,575Research paymentCash or cash equivalentELAPRASE Biological, GENETIC DISEASEAN OPEN LABEL EXTENSION OF STUDY HGT-HIT-094 EVALUATING LONG TERM SAFETY AND CLINICAL OUTCOMES OF INTRATHECAL IDURSULFAS2024
2024-09-05Genmab U.S., Inc.$18,319Research paymentCash or cash equivalentEpkinly Drug, OncologyA Phase 1/2, Open-Label Safety Trial of GEN3013 in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma.2024
2024-09-05Alnylam Pharmaceuticals Inc.$900Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2024
2024-09-05Tandem Diabetes Care, Inc.$300Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2024
2024-08-28Tandem Diabetes Care, Inc.$700Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2024
2024-08-22Genmab U.S., Inc.$16,670Research paymentCash or cash equivalentEpkinly Drug, OncologyA Phase 1/2, Open-Label Safety Trial of GEN3013 in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma.2024
2024-08-22Insulet Corporation$1,100Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentOmnipod Device, Insulin Pump2024
2024-08-21Genentech USA, Inc.$100,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentOcrevus Biological, Immunology2024
2024-08-21Tandem Diabetes Care, Inc.$700Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2024
2024-08-18Monteris Medical Corporation$264Research paymentIn-kind items and servicesNeuroBlate Device, NeuroBlateLITT2024
2024-08-15Zimmer Biomet Holdings, Inc.$5,604Space rental or facility fees (teaching hospital only)Cash or cash equivalentJuggerknotless Soft Anchor Device, Sports Medicine2024
2024-08-15ConvaTec Inc.$251GrantIn-kind items and servicesNATURABILAM W/INVISICTFPOKIT70MM Device, OSTOMY CARE2024
2024-08-13Olympus America Inc.$9,851Debt forgivenessIn-kind items and servicesURETERO-RENO VIDEOSCOPE Device, Urology Gynecology2024
2024-08-13Olympus America Inc.$5,826Debt forgivenessIn-kind items and servicesEVIS EXERA III BRONCHOVIDEOSCOPE Device, Gastroenterology2024
2024-08-12INSTRUMENTATION LABORATORY COMPANY$10,916Research paymentIn-kind items and services2024
2024-08-08Genmab U.S., Inc.$4,848Research paymentCash or cash equivalentEpkinly Drug, OncologyA Phase 1/2, Open-Label Safety Trial of GEN3013 in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma.2024
2024-08-08Alnylam Pharmaceuticals Inc.$1,450Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2024
2024-08-07Tandem Diabetes Care, Inc.$400Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2024
2024-08-02Genmab U.S., Inc.$39,476Research paymentCash or cash equivalentEpkinly Drug, OncologyA Phase 1/2, Open-Label Safety Trial of GEN3013 in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma.2024
2024-08-01Insulet Corporation$550Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentOmnipod Device, Insulin Pump2024
2024-07-26National Marrow Donor Program$25,090Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2024
2024-07-26Insulet Corporation$550Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentOmnipod Device, Insulin Pump2024
2024-07-25Genmab U.S., Inc.$24,768Research paymentCash or cash equivalentEpkinly Drug, OncologyA Phase 1/2, Open-Label Safety Trial of GEN3013 in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma.2024
2024-07-24Tandem Diabetes Care, Inc.$400Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2024
2024-07-05Takeda Pharmaceuticals U.S.A., Inc.$848Research paymentCash or cash equivalentGATTEX Drug, INTERNAL MEDICINEA PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME2024
2024-07-05Takeda Pharmaceuticals U.S.A., Inc.$848Research paymentCash or cash equivalentGATTEX Drug, INTERNAL MEDICINEA PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME2024
2024-07-05Takeda Pharmaceuticals U.S.A., Inc.$848Research paymentCash or cash equivalentGATTEX Drug, INTERNAL MEDICINEA PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME2024
2024-07-03Tandem Diabetes Care, Inc.$300Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2024
2024-07-02AtriCure, Inc.$13,286Research paymentCash or cash equivalentATRICLIP LAA EXCLUSION SYSTEM Device, CARDIOVASCULARLEFT ATRIAL APPENDAGE EXCLUSION FOR PROPHYLACTIC STROKE REDUCTION TRIAL2024
2024-07-02Alnylam Pharmaceuticals Inc.$1,250Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2024
2024-06-26Genmab U.S., Inc.$10,147Research paymentCash or cash equivalentEpkinly Drug, OncologyA Phase 1/2, Open-Label Safety Trial of GEN3013 in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma.2024
2024-06-26Tandem Diabetes Care, Inc.$400Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2024
2024-06-06Genmab U.S., Inc.$83,112Research paymentCash or cash equivalentEpkinly Drug, OncologyA Phase 1/2, Open-Label Safety Trial of GEN3013 in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma.2024
2024-06-06Alnylam Pharmaceuticals Inc.$4,750Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2024
2024-06-05Tandem Diabetes Care, Inc.$400Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2024
2024-05-30Genmab U.S., Inc.$19,856Research paymentCash or cash equivalentEpkinly Drug, OncologyA Phase 1/2, Open-Label Safety Trial of GEN3013 in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma.2024
2024-05-30Genmab U.S., Inc.$6,530Research paymentCash or cash equivalentEpkinly Drug, OncologyA Phase 1/2, Open-Label Safety Trial of GEN3013 in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma.2024
2024-05-30Genmab U.S., Inc.$5,273Research paymentCash or cash equivalentEpkinly Drug, OncologyA Phase 1/2, Open-Label Safety Trial of GEN3013 in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma.2024
2024-05-29Takeda Pharmaceuticals U.S.A., Inc.$21,640Research paymentIn-kind items and servicesNINLARO Drug, ONCOLOGYX16104: A PHASE II STUDY OF IXAZOMIB, LENALIDOMIDE, DEXAMETHASONE, AND DARATUMUMAB IN TRANSPLANT-INELIGIBLE PATIENTS WIT2024
2024-05-22Insulet Corporation$2,025Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentOmnipod Device, Insulin Pump2024
2024-05-16XVIVO Perfusion Inc.$130,304Research paymentCash or cash equivalentXVIVO Heartbox and its components Device, Transplant PerfusionPRESERVE Heart Study2024
2024-05-16Insulet Corporation$3,300Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentOmnipod Device, Insulin Pump2024
2024-05-16Tandem Diabetes Care, Inc.$250Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2024
2024-04-26National Marrow Donor Program$12,520Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2024
2024-04-25Zimmer Biomet Holdings, Inc.$18,858Space rental or facility fees (teaching hospital only)Cash or cash equivalentPersona Device, Knees2024
2024-04-24Tandem Diabetes Care, Inc.$800Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2024
2024-04-17Tandem Diabetes Care, Inc.$400Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2024
2024-04-12Takeda Pharmaceuticals U.S.A., Inc.$1,500Space rental or facility fees (teaching hospital only)Cash or cash equivalent2024
2024-04-10Tandem Diabetes Care, Inc.$400Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2024
2024-04-02Insulet Corporation$2,750Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentOmnipod Device, Insulin Pump2024
2024-03-29W. L. Gore & Associates, Inc.$504Research paymentCash or cash equivalentProduct in Development Device, DevicesGREAT Global Registry for Endovascular Aortic Treatment2024
2024-03-27Tandem Diabetes Care, Inc.$400Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2024
2024-03-26Takeda Pharmaceuticals U.S.A., Inc.$1,315Research paymentCash or cash equivalentA RANDOMIZED, OPEN-LABEL, PHASE 3 TRIAL OF A+AVD VERSUS ABVD AS FRONTLINE THERAPY IN PATIENTS WITH ADVANCED CLASSICAL HO2024
2024-03-25Takeda Pharmaceuticals U.S.A., Inc.$12,984Research paymentIn-kind items and servicesNINLARO Drug, ONCOLOGYX16104: A PHASE II STUDY OF IXAZOMIB, LENALIDOMIDE, DEXAMETHASONE, AND DARATUMUMAB IN TRANSPLANT-INELIGIBLE PATIENTS WIT2024
2024-03-22Takeda Pharmaceuticals U.S.A., Inc.$1,716Research paymentCash or cash equivalentELAPRASE Biological, GENETIC DISEASEHUNTER OUTCOME SURVEY: A GLOBAL, MULTI-CENTER, LONG-TERM, OBSERVATIONAL REGISTRY OF PATIENTS WITH HUNTER SYNDROME (MUCOP2024
2024-03-22Insulet Corporation$550Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentOmnipod Device, Insulin Pump2024
2024-03-20Tandem Diabetes Care, Inc.$250Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2024
2024-03-07Genmab U.S., Inc.$229,415Research paymentCash or cash equivalentEpkinly Drug, OncologyA Phase 1/2, Open-Label Safety Trial of GEN3013 in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma.2024
2024-03-06Takeda Pharmaceuticals U.S.A., Inc.$750Research paymentCash or cash equivalentELAPRASE Biological, GENETIC DISEASEHUNTER OUTCOME SURVEY: A GLOBAL, MULTI-CENTER, LONG-TERM, OBSERVATIONAL REGISTRY OF PATIENTS WITH HUNTER SYNDROME (MUCOP2024
2024-03-06Takeda Pharmaceuticals U.S.A., Inc.$250Research paymentCash or cash equivalentELAPRASE Biological, GENETIC DISEASEHUNTER OUTCOME SURVEY: A GLOBAL, MULTI-CENTER, LONG-TERM, OBSERVATIONAL REGISTRY OF PATIENTS WITH HUNTER SYNDROME (MUCOP2024
2024-03-05Insulet Corporation$1,650Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentOmnipod Device, Insulin Pump2024
2024-03-04Incyte Corporation$850Space rental or facility fees (teaching hospital only)Cash or cash equivalentMONJUVI Drug, Oncology2024
2024-02-28Tandem Diabetes Care, Inc.$500Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2024
2024-02-22Insulet Corporation$2,025Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentOmnipod Device, Insulin Pump2024
2024-02-21Tandem Diabetes Care, Inc.$250Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2024
2024-02-08Tandem Diabetes Care, Inc.$800Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2024
2024-02-05Insulet Corporation$1,650Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentOmnipod Device, Insulin Pump2024
2024-01-31Tandem Diabetes Care, Inc.$1,050Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2024
2024-01-24Tandem Diabetes Care, Inc.$400Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2024
2024-01-12National Marrow Donor Program$16,565Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2024
2024-01-12Incyte Corporation$2,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentJAKAFI Drug, Hematology/Oncology2024
2024-01-10Takeda Pharmaceuticals U.S.A., Inc.$3,780Research paymentCash or cash equivalentELAPRASE Biological, GENETIC DISEASEAN OPEN LABEL EXTENSION OF STUDY HGT-HIT-094 EVALUATING LONG TERM SAFETY AND CLINICAL OUTCOMES OF INTRATHECAL IDURSULFAS2024
2024-01-10Tandem Diabetes Care, Inc.$250Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2024
2024-01-03Tandem Diabetes Care, Inc.$1,300Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2024
2024-01-03Takeda Pharmaceuticals U.S.A., Inc.$848Research paymentCash or cash equivalentGATTEX Drug, INTERNAL MEDICINEA PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME2024
2024-01-03Takeda Pharmaceuticals U.S.A., Inc.$848Research paymentCash or cash equivalentGATTEX Drug, INTERNAL MEDICINEA PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME2024
2024-01-03Takeda Pharmaceuticals U.S.A., Inc.$848Research paymentCash or cash equivalentGATTEX Drug, INTERNAL MEDICINEA PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME2024

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Douglas CountyOmaha city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Omaha, NE, county Douglas County, NE, state Nebraska; placed by its city name.

MeasurePlace (city or town)
Omaha, NE
County
Douglas County, NE
State
Nebraska
Population B01003488,837590,7361,978,707
Population, 2020 census P1486,051584,5261,961,504
Median age B0100235.335.637.2
Under 18 B0100124.2%25.3%24.5%
65 and over B0100114.5%14.1%16.7%
Households B11001201,698238,430797,847
Foreign born B0500211.3%10.6%8.0%
Median household income B19013$73,201$80,391$76,475
Median family income B19113$99,432$108,805$99,751
Per capita income B19301$43,638$46,334$41,751
Poverty rate B1700113.5%11.8%10.6%
Unemployment rate B230254.2%3.8%3.0%
Civilian labor force B23025264,681320,0241,056,746
Mean commute (minutes) B0801319.620.019.2
Bachelor's degree or higher B1500340.1%42.1%34.6%
Housing units B25001213,023251,553863,444
Owner-occupied B2500357.4%61.5%66.5%
Renters B2500342.6%38.5%33.5%
Median home value B25077$245,500$266,100$238,600
Median gross rent B25064$1,187$1,201$1,072
White, not Hispanic B0300263.4%65.8%75.3%
Black B0300211.4%10.2%4.6%
Hispanic or Latino B0300216.2%14.5%12.7%
Asian B030024.0%4.4%2.6%
American Indian and Alaska Native B030020.2%0.2%0.6%

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Omaha, NE.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.